Overview
As the world becomes more complex, writers struggle to play a fine balancing act between dealing with more complex challenges such as authoring complex protocols, drafting risk management plans, publication planning, authoring aggregate reports, drafting comprehensive economic and outcomes literature reviews, to stepping down the complexity a notch, trashing the jargon and developing the art of authoring lay language summaries, understanding the value and nuances of QC'g safety narratives and balancing the freedom of expression with the importance of compliance. It is a tight rope walk, with the need to stay abreast with the latest tools and technologies, evolving regulations and yet not lose the fine art if writing.”
Program Committee
-
Nimita Limaye, PhD Research Vice President, Life Sciences R&D Strategy and Technology
IDC, United States -
Ashwini Patil Expert Scientific Writer
Novartis Healthcare Pvt. Ltd., India -
Bindu Narang Executive Director - Patient Safety Solutions
Labcorp, India -
Pooja Phogat, PhD Founder and Co-CEO
Krystelis Ltd., India -
Rajesh Kher, PhD Head of Outsourcing Partnership Management in the Capabilities group of IDAR
Janssen and Janssen Pharmaceutical Research & Development, L.L.C., India -
Roopa Basrur Vice President and Country Head
Calyx India, India
Have an account?